MX2013012229A - Composiciones nutricionales que tienen a-hica y acido eicosapentaenoico y metodos para utilizar las mismas. - Google Patents
Composiciones nutricionales que tienen a-hica y acido eicosapentaenoico y metodos para utilizar las mismas.Info
- Publication number
- MX2013012229A MX2013012229A MX2013012229A MX2013012229A MX2013012229A MX 2013012229 A MX2013012229 A MX 2013012229A MX 2013012229 A MX2013012229 A MX 2013012229A MX 2013012229 A MX2013012229 A MX 2013012229A MX 2013012229 A MX2013012229 A MX 2013012229A
- Authority
- MX
- Mexico
- Prior art keywords
- generator
- rotor
- displacing
- wind turbine
- units
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/70—Wind energy
- Y02E10/72—Wind turbines with rotation axis in wind direction
Abstract
Se proporcionan las composiciones nutricionales para maximizar la síntesis de proteína muscular y minimizar el catabolismo de las proteínas musculares y métodos para utilizar las mismas. En esta forma, las composiciones nutricionales pueden proporcionar la retención de la masa corporal magra, que ayuda a evitar la pérdida de independencia y funcionalidad, así como a mejorar la calidad de vida en especial en los ancianos en riesgo de sarcopenia y fragilidad. Las composiciones nutricionales incluyen ácido a-hidroxi-isocaproico y ácido eicosapentaenoico. Puede incluir otros ingredientes funcionales tales como, pero no limitado a proteína de suero de leche, que incluye micelas de proteína de suero de leche, fibras prebióticas, citrulina, a-cetoglutarato, L-carnitina, nucleótidos, y aminoácidos. También se proporcionan métodos para administrar tales composiciones nutricionales a los individuos que necesiten de las mismas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161476345P | 2011-04-18 | 2011-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013012229A true MX2013012229A (es) | 2013-12-06 |
Family
ID=45976400
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013012230A MX2013012230A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas. |
MX2013012231A MX2013012231A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y a-cetoglutarato y metodos para utilizar las mismas. |
MX2013012228A MX2013012228A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y metodos para utilizar las mismas. |
MX2013012229A MX2013012229A (es) | 2011-04-18 | 2013-10-18 | Composiciones nutricionales que tienen a-hica y acido eicosapentaenoico y metodos para utilizar las mismas. |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013012230A MX2013012230A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas. |
MX2013012231A MX2013012231A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y a-cetoglutarato y metodos para utilizar las mismas. |
MX2013012228A MX2013012228A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y metodos para utilizar las mismas. |
Country Status (13)
Country | Link |
---|---|
US (4) | US20140056862A1 (es) |
EP (4) | EP2699111A1 (es) |
JP (4) | JP2014512371A (es) |
CN (4) | CN103476275A (es) |
AU (4) | AU2012244751A1 (es) |
BR (2) | BR112013026706A2 (es) |
CA (4) | CA2832150A1 (es) |
MX (4) | MX2013012230A (es) |
PH (1) | PH12013502027A1 (es) |
RU (4) | RU2013151087A (es) |
SG (4) | SG194065A1 (es) |
WO (4) | WO2012143403A1 (es) |
ZA (4) | ZA201308605B (es) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2583563A1 (en) * | 2011-10-21 | 2013-04-24 | Nestec S.A. | Whey protein micelles against muscle atrophy and sarcopenia |
EP2583566B1 (en) * | 2011-10-21 | 2015-08-19 | Nestec S.A. | Whey protein micelles to enhance muscle mass and performance |
ITBO20120226A1 (it) * | 2012-04-24 | 2013-10-25 | Alfa Wassermann Spa | Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso. |
CN103783532B (zh) * | 2012-10-29 | 2016-06-08 | 杭州纽曲星生物科技有限公司 | 一种抗老年性肌肉衰减的复合蛋白质粉及其制备方法 |
CA2909211C (en) * | 2013-04-15 | 2021-06-22 | Nestec S.A. | Use of whey protein in combination with electrical muscle stimulation |
WO2014200332A1 (en) * | 2013-06-10 | 2014-12-18 | N.V. Nutricia | Muscle preservation in overweight or obese adult during weight loss program |
EP3048904A2 (en) | 2013-09-25 | 2016-08-03 | Pronutria Biosciences, Inc. | Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof |
EP3054938A1 (en) * | 2013-10-09 | 2016-08-17 | Nestec S.A. | Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome |
CN103637212B (zh) * | 2013-12-13 | 2014-12-24 | 广东省农业科学院蚕业与农产品加工研究所 | 一种具有降血脂作用的管饲临床营养品及其制备方法 |
EP3115047B1 (en) * | 2014-03-07 | 2020-05-06 | Ajinomoto Co., Inc. | Debility preventative |
JPWO2015137387A1 (ja) * | 2014-03-11 | 2017-04-06 | 協和発酵バイオ株式会社 | 筋肉増強剤 |
SG11201607831TA (en) | 2014-03-26 | 2016-10-28 | Abbott Lab | Nutritional supplement powder |
WO2015151066A1 (en) * | 2014-04-04 | 2015-10-08 | Polifenoles Naturales, S.L. | Treatment of sarcopenia with ecdysteroids |
WO2015160262A1 (en) * | 2014-04-16 | 2015-10-22 | Amerikal Nutraceutical Corp | Anti-aging composition |
CN104027340B (zh) * | 2014-05-14 | 2018-08-24 | 田芳 | 一种含有三水合乳果糖组合物的可溶性粉剂及其制备方法 |
EP3151686A2 (en) * | 2014-06-03 | 2017-04-12 | Abbott Laboratories | Potato based protein mixtures and nutritional compositions comprising potato protein |
US11102994B2 (en) * | 2014-08-21 | 2021-08-31 | Clearfast Inc. | Pre-operative carbohydrate-rich beverage composition and methods of treatment |
WO2016044167A1 (en) * | 2014-09-15 | 2016-03-24 | Abbott Laboratories | Methods for increasing muscle strength and mobility in subjects experiencing significant physical inactivity using gamma linolenic acid |
CA2963182C (en) * | 2014-10-14 | 2023-10-17 | Nestec S.A. | Improvement in muscle functionality of elderly males |
US11040022B2 (en) * | 2015-02-05 | 2021-06-22 | William H. Cross, III | Compositions and methods for pain relief |
NL2015032B1 (en) | 2015-06-26 | 2017-01-24 | Vitalnext B V | Compositions and methods for the treatment of malnutrition. |
EP3368498A4 (en) | 2015-10-27 | 2019-06-12 | Cytozyme Animal Nutrition, Inc. | ANIMAL NUTRITIONAL COMPOSITIONS AND RELATED METHODS |
US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
RU2614881C1 (ru) * | 2015-12-29 | 2017-03-30 | Общество с ограниченной ответственностью "Мобильный доктор" | Комплекс биологически активных веществ, защищающих спортсменов от перетренированности |
CN108369223B (zh) * | 2015-12-30 | 2021-07-06 | 雀巢产品有限公司 | 用于测定去脂体重的方法 |
WO2017151540A1 (en) | 2016-02-29 | 2017-09-08 | Abbott Laboratories | Nutritional supplement powder |
US11612632B2 (en) | 2017-04-25 | 2023-03-28 | William H. Cross, III | Compositions and methods for treatment of prediabetes |
ES2851923T3 (es) * | 2016-05-20 | 2021-09-09 | Nestle Sa | Triglicéridos de cadena intermedia para el tratamiento de enfermedad degenerativa de la válvula mitral en animales de compañía |
CN106213522A (zh) * | 2016-08-05 | 2016-12-14 | 郑家福 | 营养保健品 |
RU2635373C1 (ru) * | 2016-08-25 | 2017-11-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Биологически активная добавка для повышения общей работоспособности |
TW202247855A (zh) | 2016-09-13 | 2022-12-16 | 美商愛力根公司 | 非蛋白梭菌毒素組成物 |
AU2017361804B2 (en) * | 2016-11-16 | 2021-09-09 | Fresenius Kabi Deutschland Gmbh | Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
KR20180081361A (ko) * | 2017-01-06 | 2018-07-16 | 연세대학교 산학협력단 | 인돌-3-카비놀 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용 조성물 |
SG10202107237SA (en) * | 2017-04-25 | 2021-08-30 | Buck Inst Res Aging | Formulations for extending lifespan and healthspan |
SG11201912551UA (en) | 2017-06-21 | 2020-01-30 | Abbott Lab | Methods for increasing growth of beneficial bacteria in the gastrointestinal tract |
CN107242572A (zh) * | 2017-07-06 | 2017-10-13 | 广州彤博士健康科技有限公司 | 营养补充剂及制备方法 |
TWI775921B (zh) | 2017-08-14 | 2022-09-01 | 美商胺細拉健康公司 | 用於治療和高血氨症或肌肉耗損中之一者或兩者相關之肝疾病及失調之組合物及方法 |
CN107616505B (zh) * | 2017-10-24 | 2020-12-25 | 精晶药业股份有限公司 | 一种含有鸟氨酸酮戊二酸的保健品及其制备方法 |
PL238310B1 (pl) * | 2017-10-31 | 2021-08-09 | Top Energy Set Spolka Z Ograniczona Odpowiedzialnoscia | Preparat leczniczy oraz sposób jego uzyskiwania |
US11154523B2 (en) | 2018-01-31 | 2021-10-26 | William H. Cross, III | Compositions and methods for treatment of diabetic neuropathies |
US11351188B2 (en) | 2018-01-31 | 2022-06-07 | William H. Cross, III | Folic compositions and methods for treatment of diabetic neuropathies |
US11304971B2 (en) | 2018-01-31 | 2022-04-19 | William H. Cross, III | Metformin compositions and methods for treatment of diabetes |
JP2021527670A (ja) | 2018-06-20 | 2021-10-14 | アクセラ・ヘルス・インコーポレイテッドAxcella Health Inc. | 筋肉中の脂肪浸潤の治療のための組成物及び方法 |
US11802103B2 (en) | 2018-09-25 | 2023-10-31 | Ponce De Leon Health Designated Activity Company | Process of making calcium alpha-ketoglutarate |
WO2020106746A1 (en) * | 2018-11-19 | 2020-05-28 | Heh Research & Development Services, Inc. | Biologic enhancement formulation |
KR102171518B1 (ko) * | 2019-02-21 | 2020-10-29 | 한양대학교 에리카산학협력단 | 지골피 추출물을 유효성분으로 함유하는 근 위축 예방 또는 치료용 조성물 |
EP3934441A1 (en) * | 2019-05-31 | 2022-01-12 | Société des Produits Nestlé S.A. | Mct-based nutrition blend for providing health benefits in animals |
CN114126599A (zh) * | 2019-06-10 | 2022-03-01 | 巴克老龄化研究所 | 改变衰老相关分泌表型的方法和组合物 |
CN110226756A (zh) * | 2019-06-18 | 2019-09-13 | 山东理工大学 | 预防和缓解2型糖尿病患者肌少症的蛋白组件及制备方法 |
TWI774966B (zh) * | 2019-06-25 | 2022-08-21 | 生合生物科技股份有限公司 | 胚芽乳桿菌bcrc 910734用於提升老年個體的肌力以及治療肌肉減少症的用途 |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
US20210196772A1 (en) * | 2019-12-27 | 2021-07-01 | Grove Collaborative, Inc. | Confections for skin protection: compositions, methods for making, and applications thereof |
MX2022011963A (es) * | 2020-03-30 | 2022-10-20 | Gervais Danone Sa | Composiciones de leche fermentada para su uso en metodos de suplementacion nutricional. |
FI129515B (en) * | 2020-11-06 | 2022-03-31 | Salarusta Oy | FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY |
CN112899204B (zh) * | 2021-03-19 | 2022-06-28 | 杭州百芮生物科技有限公司 | 一种益生菌冻干外壳复合保护剂及其应用 |
CN113398144B (zh) * | 2021-07-27 | 2022-04-01 | 陈玉松 | 核苷酸混合物在制备预防或缓解老年肌少症制剂中的应用 |
CN114029085B (zh) * | 2021-12-06 | 2024-02-27 | 中触媒新材料股份有限公司 | 一种烯烃环氧化催化剂及其制备方法和应用 |
WO2023121696A1 (en) * | 2021-12-20 | 2023-06-29 | Schneider Todd C | Formulation and treatment for extended micronutrient therapy |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2335215B2 (de) * | 1972-07-13 | 1979-04-05 | The Johns Hopkins University, Baltimore, Md. (V.St.A.) | Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen |
GB1444621A (en) * | 1973-04-30 | 1976-08-04 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogues of amino acids |
GB1442154A (en) * | 1973-04-30 | 1976-07-07 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body |
GB1511302A (en) * | 1974-04-15 | 1978-05-17 | Univ Johns Hopkins | Pharmaceutical compositions comprising amino acid analogues |
US4752619A (en) | 1985-12-23 | 1988-06-21 | The Johns Hopkins University | Nutritional supplement for treatment of uremia |
SE8803144L (sv) * | 1988-09-07 | 1990-03-08 | Kabivitrum Ab | Energisubstrat |
SE9201584D0 (sv) * | 1992-05-20 | 1992-05-20 | Vinnars Erik Ab | Use of alpha-ketoglutarate |
US5646187A (en) * | 1992-05-20 | 1997-07-08 | Ab Erik Vinnars | Use of alpha-ketoglutarate |
SE0201713D0 (sv) * | 2001-11-23 | 2002-06-06 | Gramineer Internat Ab | New methods and use III |
US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
US8795693B2 (en) * | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
WO2005107735A2 (en) * | 2004-04-30 | 2005-11-17 | Pump Formulations, Ltd. | Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, incresing nutrient delivery and/or promoting increased vascular response in a |
FI20045395A (fi) * | 2004-10-21 | 2006-04-22 | Elmomed Ltd Oy | Ravintoainelisä ja sen käyttö |
WO2007082914A2 (en) * | 2006-01-19 | 2007-07-26 | Entress Ab | Method of diagnosis and method of treatment |
CN101179943B (zh) * | 2005-05-23 | 2013-06-26 | 卡夫食品环球品牌有限责任公司 | 填充液体的咀嚼型胶基糖组合物 |
EP2305046A3 (en) * | 2005-05-23 | 2014-04-09 | Intercontinental Great Brands LLC | Taste potentiator compositions and beverages containing the same |
EP1774973A1 (en) * | 2005-10-12 | 2007-04-18 | Nutricia N.V. | Leucine rich composition |
WO2007053943A1 (en) * | 2005-11-08 | 2007-05-18 | Multi Formulations Ltd. | The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance |
DE602006008985D1 (de) * | 2005-12-16 | 2009-10-15 | Nutricia Nv | Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund |
JP2009527504A (ja) * | 2006-02-23 | 2009-07-30 | イオメディックス スリープ インターナショナル エスアールエル | 良質な睡眠の誘導および維持のための組成物および方法 |
WO2007108827A1 (en) * | 2006-03-23 | 2007-09-27 | Nestec S.A. | High-calorie nutritional supplement |
CN101415414B (zh) * | 2006-04-04 | 2013-06-12 | 雀巢产品技术援助有限公司 | 瓜氨酸在制备治疗矫正脓毒症患者中精氨酸缺乏的药物中的用途 |
CA2778823A1 (en) * | 2006-04-04 | 2007-10-11 | Nestec S.A. | Treatments using citrulline |
PL379512A1 (pl) * | 2006-04-21 | 2007-10-29 | Sgp & Sons Ab | Nowe metody i ich zastosowanie |
MX2009001422A (es) * | 2006-08-09 | 2009-02-19 | Iams Company | Metodos para mejorar la salud osea y la salud muscular. |
FR2913885B1 (fr) * | 2007-03-22 | 2012-07-20 | Univ Paris Descartes | Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines |
WO2009033250A1 (en) * | 2007-09-11 | 2009-03-19 | Multi Formulations Ltd. | Composition and method for increasing the anabolic state of muscle cells |
CA2610820A1 (en) * | 2007-12-12 | 2008-12-29 | Michele Molino | Method for maintaining physiological ph levels during intensive physical exercise |
US20090156647A1 (en) * | 2007-12-12 | 2009-06-18 | Iovate T. & P. Inc. | Method for maintaining physiological pH levels during intensive physical exercise |
WO2010002242A1 (en) * | 2008-07-02 | 2010-01-07 | N.V. Nutricia | Nutritional composition for improving muscle function and daily activity |
JP2010105946A (ja) * | 2008-10-29 | 2010-05-13 | Nof Corp | 筋タンパク質増強剤及びこれを含む医薬品または食品 |
WO2010108016A2 (en) * | 2009-03-18 | 2010-09-23 | Healthspan Solutions, Llc | Compositions and methods for sparing muscle in renal insufficiency and during hemodialysis |
WO2010137944A1 (en) * | 2009-05-27 | 2010-12-02 | N.V. Nutricia | Treatment of hypercalcaemia |
JP2012533627A (ja) * | 2009-07-20 | 2012-12-27 | ネステク ソシエテ アノニム | 機能状態の喪失を減弱する方法 |
EP2464246A2 (en) * | 2009-08-13 | 2012-06-20 | Nestec S.A. | Nutritional compositions including exogenous nucleotides |
ES2669004T3 (es) * | 2009-09-14 | 2018-05-23 | Nestec S.A. | Composiciones nutricionales para modular la inflamación, que incluyen vitamina K2 exógena |
-
2012
- 2012-04-18 WO PCT/EP2012/057093 patent/WO2012143403A1/en active Application Filing
- 2012-04-18 US US14/112,746 patent/US20140056862A1/en not_active Abandoned
- 2012-04-18 JP JP2014505604A patent/JP2014512371A/ja active Pending
- 2012-04-18 MX MX2013012230A patent/MX2013012230A/es unknown
- 2012-04-18 WO PCT/EP2012/057092 patent/WO2012143402A1/en active Application Filing
- 2012-04-18 MX MX2013012231A patent/MX2013012231A/es unknown
- 2012-04-18 EP EP12718133.7A patent/EP2699111A1/en not_active Withdrawn
- 2012-04-18 MX MX2013012228A patent/MX2013012228A/es unknown
- 2012-04-18 CA CA2832150A patent/CA2832150A1/en not_active Abandoned
- 2012-04-18 SG SG2013073986A patent/SG194065A1/en unknown
- 2012-04-18 CN CN2012800190607A patent/CN103476275A/zh active Pending
- 2012-04-18 CN CN2012800179097A patent/CN103458710A/zh active Pending
- 2012-04-18 CA CA2831165A patent/CA2831165A1/en not_active Abandoned
- 2012-04-18 WO PCT/EP2012/057095 patent/WO2012143405A1/en active Application Filing
- 2012-04-18 AU AU2012244751A patent/AU2012244751A1/en not_active Abandoned
- 2012-04-18 RU RU2013151087/13A patent/RU2013151087A/ru not_active Application Discontinuation
- 2012-04-18 JP JP2014505603A patent/JP2014519483A/ja active Pending
- 2012-04-18 CA CA2831001A patent/CA2831001A1/en not_active Abandoned
- 2012-04-18 SG SG2013071386A patent/SG193933A1/en unknown
- 2012-04-18 US US14/112,779 patent/US20140056863A1/en not_active Abandoned
- 2012-04-18 AU AU2012244749A patent/AU2012244749A1/en not_active Abandoned
- 2012-04-18 CN CN201280019059.4A patent/CN103491804A/zh active Pending
- 2012-04-18 CN CN2012800190556A patent/CN103476274A/zh active Pending
- 2012-04-18 RU RU2013151090/13A patent/RU2013151090A/ru not_active Application Discontinuation
- 2012-04-18 SG SG2013071626A patent/SG193938A1/en unknown
- 2012-04-18 BR BR112013026706A patent/BR112013026706A2/pt not_active IP Right Cessation
- 2012-04-18 SG SG2013073465A patent/SG194028A1/en unknown
- 2012-04-18 JP JP2014505605A patent/JP2014512372A/ja active Pending
- 2012-04-18 WO PCT/EP2012/057094 patent/WO2012143404A1/en active Application Filing
- 2012-04-18 EP EP12715104.1A patent/EP2699110A1/en not_active Withdrawn
- 2012-04-18 JP JP2014505606A patent/JP2014511890A/ja active Pending
- 2012-04-18 US US14/112,785 patent/US20140044685A1/en not_active Abandoned
- 2012-04-18 EP EP12719308.4A patent/EP2699113A1/en not_active Withdrawn
- 2012-04-18 BR BR112013026539A patent/BR112013026539A2/pt not_active IP Right Cessation
- 2012-04-18 US US14/112,744 patent/US20140037604A1/en not_active Abandoned
- 2012-04-18 AU AU2012244750A patent/AU2012244750A1/en not_active Abandoned
- 2012-04-18 RU RU2013151085/13A patent/RU2013151085A/ru not_active Application Discontinuation
- 2012-04-18 RU RU2013151083/13A patent/RU2013151083A/ru not_active Application Discontinuation
- 2012-04-18 AU AU2012244748A patent/AU2012244748B2/en not_active Ceased
- 2012-04-18 CA CA2832507A patent/CA2832507A1/en not_active Abandoned
- 2012-04-18 EP EP12719307.6A patent/EP2699112A1/en not_active Withdrawn
-
2013
- 2013-09-30 PH PH12013502027A patent/PH12013502027A1/en unknown
- 2013-10-18 MX MX2013012229A patent/MX2013012229A/es not_active Application Discontinuation
- 2013-11-15 ZA ZA2013/08605A patent/ZA201308605B/en unknown
- 2013-11-15 ZA ZA2013/08604A patent/ZA201308604B/en unknown
- 2013-11-15 ZA ZA2013/08606A patent/ZA201308606B/en unknown
- 2013-11-15 ZA ZA2013/08607A patent/ZA201308607B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013012229A (es) | Composiciones nutricionales que tienen a-hica y acido eicosapentaenoico y metodos para utilizar las mismas. | |
MX346727B (es) | Instalación de energía eólica. | |
EP2590304A3 (en) | Wind turbine generator and wind turbine | |
MX2014007258A (es) | Gondola de instalacion de energia eolica. | |
EP2458160A3 (en) | Aircraft gas turbine engine comprising a generator | |
WO2012120485A3 (en) | Fluid-cooled wind turbine | |
WO2012100783A3 (en) | Hydraulic transmission methods and apparatus for wind turbines | |
WO2013014015A3 (en) | A vortex generator arrangement for an airfoil | |
WO2012073277A3 (en) | Wind turbine generator and tidal current generator | |
EP2562085A3 (en) | De-icing system for modular counter rotating propeller | |
MX2014013458A (es) | Generador para instalacion de energia eolica sin engranajes. | |
DK201170721A (en) | Modular rotor blade and method for mounting a wind turbine | |
BRPI1005505A2 (pt) | estrutura de bomba hidráulica para um gerador de turbina eólica ou um gerador de corrente de maré, e, método para montar uma bomba hidráulica do gerador de turbina eólica ou do gerador de corrente de maré. | |
EP2938879A4 (en) | WIND ROTOR SHAFT ARRANGEMENT | |
MX353872B (es) | Generador síncrono de turbina de energía eólica sin engranaje. | |
NZ701728A (en) | Rotor blade for a wind power plant | |
NZ627654A (en) | Wind turbine rotor | |
WO2015106891A3 (de) | Synchrongenerator einer getriebelosen windenergieanlage | |
IN2014DN09761A (es) | ||
WO2012059463A3 (de) | Windenergieanlage mit synchrongenerator sowie langsam drehender synchrongenerator | |
WO2014009011A3 (de) | Windenergieanlage mit einem pitchverstellsystem | |
DK201070543A (en) | Direct drive segmented generator | |
WO2013189733A3 (de) | Windpark mit mehreren netzeinspeisepunkten | |
AR087808A1 (es) | Unidad auxiliar de turbina de energia eolica | |
WO2012064112A3 (ko) | 수직축 풍력발전 장치의 블레이드 구조 및 이를 이용한 풍력발전시스템 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |